Resource Library
This section provides immediate access to all of the resources
that we have on our site in both HTML and PDF formats.
For the Public

For Health Care Professionals

Medical and Treatment Guidelines

For Educators

Hepatitis C Prevention, Support & Research Program
- For publications pertaining to the Program, please click here.

Articles by Section Members
- Jayaraman GC, Lee B, Singh AE, Preiksaitis JK. Trends in testing behaviours for hepatitis C virus infection and associated determinants: results from population-based laboratory surveillance in Alberta, Canada
(1998-2001). J Viral Hepat. April 2007;14(4):249-254.
- Wu HX, Wu J, Wong T, Donaldson T, Dinner K, Andonov A, Ip Chan J, Moffat B, Baptiste B, Furseth J, Poliquin D, Bolesnikov G, Giulivi A, Paton S. Enhanced surveillance of newly acquired hepatitis C virus infection in Canada, 1998 to 2004
. Scand J Infect Dis 2006;38(6-7):482-9.
- Wu H-X, Wu J, Wong T, Andonov A, Li Q, Dinner K, Donaldson T, Paton S, Enhanced Hepatitis Strain Surveillance System (c/o MHuard). Incidence and risk factors for newly acquired hepatitis C virus infection among Aboriginal versus non-Aboriginal Canadians in six regions, 1999-2004
. Eur J Clin Microbiol Infect Dis. Mar 2006;26(3):167-174.
- Wong T, Lee SS. Review. Hepatitis C: a review for primary care physicians
. CMAJ Feb 28, 2006; 174(5):640-659.
Correction : In the article, the correct sentence is "For analgesia, small doses of ASA (< 2 g/d) are vastly preferable to NSAIDs in patients with liver disease." The medication is acetaminophen instead of ASA as printed.
- Dinner K, Donaldson T, Potts J, Sirna J, Wong T. Hepatitis C: a public health perspective and related implications for physicians
. Royal College Outlook, Fall 2005;2(3):20:22.
|